FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q73174775> ?p ?o ?g. }

• Q73174775 description "articolo scientifico (pubblicato il 1997)" @default.
• Q73174775 description "artikull shkencor i botuar më 01 janar 1997" @default.
• Q73174775 description "artículu científicu espublizáu en xineru de 1997" @default.
• Q73174775 description "im Jahr 1997 veröffentlichter wissenschaftlicher Artikel" @default.
• Q73174775 description "scientific article published on 01 January 1997" @default.
• Q73174775 description "wetenschappelijk artikel" @default.
• Q73174775 description "наукова стаття, опублікована в січні 1997" @default.
• Q73174775 name "Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer. Finnbladder III Group" @default.
• Q73174775 name "Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer. Finnbladder III Group" @default.
• Q73174775 name "Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer. Finnbladder III Group" @default.
• Q73174775 type Item @default.
• Q73174775 label "Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer. Finnbladder III Group" @default.
• Q73174775 label "Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer. Finnbladder III Group" @default.
• Q73174775 label "Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer. Finnbladder III Group" @default.
• Q73174775 prefLabel "Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer. Finnbladder III Group" @default.
• Q73174775 prefLabel "Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer. Finnbladder III Group" @default.
• Q73174775 prefLabel "Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer. Finnbladder III Group" @default.
• Q73174775 P1433 Q73174775-E8595E1E-F927-49B1-87F1-1B84ACF8BC71 @default.
• Q73174775 P1476 Q73174775-7FC8FAAA-58F5-415B-84BE-248127AADEE6 @default.
• Q73174775 P2093 Q73174775-19F46738-79EC-4159-B912-D0EC1EBF60E1 @default.
• Q73174775 P2093 Q73174775-5C277773-62E3-4604-A64A-5213DF0DC126 @default.
• Q73174775 P2093 Q73174775-BFE8AE2F-EC81-496C-9C54-415D426400B3 @default.
• Q73174775 P2093 Q73174775-DD1EBC98-7E1D-4F23-BCBE-8B285B224C93 @default.
• Q73174775 P2860 Q73174775-05DE8B47-7F97-4940-8E55-4D26698ADB63 @default.
• Q73174775 P2860 Q73174775-1B96BA6A-BA72-46D2-9CDC-BEDEB0A823E6 @default.
• Q73174775 P2860 Q73174775-1F421090-CED3-44B4-B49E-5390E5D20EAF @default.
• Q73174775 P2860 Q73174775-2A7800F5-6CC6-42DD-9F4F-DA9F8BD6DF9F @default.
• Q73174775 P2860 Q73174775-2E2C72F9-5014-4DCF-8859-5D32FD908BC3 @default.
• Q73174775 P2860 Q73174775-2EC83DD7-C4AF-4013-A05F-F34A9F0BE27E @default.
• Q73174775 P2860 Q73174775-34171C7A-850E-47E1-96E5-2E055D084D99 @default.
• Q73174775 P2860 Q73174775-38112CEF-C768-4CD1-A414-EAA0759E484E @default.
• Q73174775 P2860 Q73174775-398BDB21-EA71-44E0-A1AF-2952B54A3B27 @default.
• Q73174775 P2860 Q73174775-3B58E549-FE7D-4090-BE3F-46542E69B164 @default.
• Q73174775 P2860 Q73174775-493523B9-2583-45B5-8F9E-9A2FE2F16F4B @default.
• Q73174775 P2860 Q73174775-4F14C860-3DE1-4E65-A4BB-B149519C9DE6 @default.
• Q73174775 P2860 Q73174775-50BB28EE-5C21-4FD9-97D3-163345529652 @default.
• Q73174775 P2860 Q73174775-5FECF4B5-52C2-400C-B94F-B94225347C4C @default.
• Q73174775 P2860 Q73174775-6C521768-BE08-48AF-9746-57D81906C378 @default.
• Q73174775 P2860 Q73174775-6D4C4056-97F6-460F-953D-6C18FB080EA6 @default.
• Q73174775 P2860 Q73174775-70BCE2F5-CE28-4B0F-B95D-3C93C571F9D9 @default.
• Q73174775 P2860 Q73174775-746378DF-D5ED-447D-9238-D0FA7F3BFD32 @default.
• Q73174775 P2860 Q73174775-7508CDD8-9DB6-4250-8D84-E8DF0C1E6D83 @default.
• Q73174775 P2860 Q73174775-7E5942D3-048E-437D-B0F0-3B4BFD6BCCA8 @default.
• Q73174775 P2860 Q73174775-82CE84AE-B8D3-4C7E-9508-DDE502EC8FB6 @default.
• Q73174775 P2860 Q73174775-83FEA460-1A76-4C75-9383-B2577E2E38DB @default.
• Q73174775 P2860 Q73174775-88BED813-823C-4618-9685-3753C752108E @default.
• Q73174775 P2860 Q73174775-8E8219F1-062E-4DD6-9300-3EC06C7EBD59 @default.
• Q73174775 P2860 Q73174775-8F275024-F255-4CD5-8CB9-A123716A9BD0 @default.
• Q73174775 P2860 Q73174775-9412E1E9-20EE-40C3-8A5F-B1AB0CCBF95E @default.
• Q73174775 P2860 Q73174775-942B9532-32DC-4A05-B8DB-6DD46AB8D5BD @default.
• Q73174775 P2860 Q73174775-9BB60766-1DFD-471E-BEDE-FBF9DDAB2282 @default.
• Q73174775 P2860 Q73174775-B26A4222-4A5F-482F-A385-93F47D391694 @default.
• Q73174775 P2860 Q73174775-B26C5253-CDFA-4F29-BC9A-5E03B12E0F93 @default.
• Q73174775 P2860 Q73174775-BD927627-F1FF-4257-B6C1-9C23E1C0ED27 @default.
• Q73174775 P2860 Q73174775-C578A336-50DD-4287-83DE-FD2668F4AD65 @default.
• Q73174775 P2860 Q73174775-CAD0D726-EAEC-4087-A869-B60B75B3C2CC @default.
• Q73174775 P2860 Q73174775-D2E32A1E-003F-4063-9E4C-6C67FD2CF80E @default.
• Q73174775 P2860 Q73174775-D6D25BEA-FACC-473B-A301-B5B20ACF3231 @default.
• Q73174775 P2860 Q73174775-D7EB354B-B025-444C-B5D7-47203D4AFDCF @default.
• Q73174775 P2860 Q73174775-DE865DD6-D0E4-473D-8089-4577103D86CB @default.
• Q73174775 P2860 Q73174775-E478C99C-8C61-4A74-97BD-E0EC555FB78C @default.
• Q73174775 P2860 Q73174775-E49C6DB0-D164-4B35-8D7A-DBF0927832CF @default.
• Q73174775 P2860 Q73174775-E6B27EE2-0A8D-497A-A311-9026A248ACDD @default.
• Q73174775 P2860 Q73174775-EB0AFEEA-951D-499E-B551-B3CBC5AA1382 @default.
• Q73174775 P2860 Q73174775-F14D43FD-FFC7-4D16-A16B-FC1A0FB37EB5 @default.
• Q73174775 P2860 Q73174775-FDEEC355-9DA2-46C6-8B77-20FC9D248206 @default.
• Q73174775 P304 Q73174775-6B4CC70A-532D-44DE-9751-C0696F392F84 @default.
• Q73174775 P31 Q73174775-ABA8713E-94EA-4E90-A894-113580EA04FF @default.
• Q73174775 P356 Q73174775-05A12AB5-A984-485D-B6C9-144520333410 @default.
• Q73174775 P433 Q73174775-5A2895FE-2B9B-436C-AE80-7686C3E96371 @default.
• Q73174775 P478 Q73174775-3E5B169B-A961-4144-8BEF-4F7D281705D4 @default.
• Q73174775 P577 Q73174775-0688F142-4873-4523-8027-4558BA5B904D @default.
• Q73174775 P698 Q73174775-F7D5F0B4-3E0A-413E-B56C-0F6FE13B7EC8 @default.
• Q73174775 P356 BF00941899 @default.
• Q73174775 P698 9079739 @default.
• Q73174775 P1433 Q15746542 @default.
• Q73174775 P1476 "Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer. Finnbladder III Group" @default.
• Q73174775 P2093 "K E Jauhiainen" @default.
• Q73174775 P2093 "M Helle" @default.
• Q73174775 P2093 "P K Lipponen" @default.
• Q73174775 P2093 "T J Liukkonen" @default.
• Q73174775 P2860 Q24564546 @default.
• Q73174775 P2860 Q29615031 @default.
• Q73174775 P2860 Q29618318 @default.
• Q73174775 P2860 Q33733805 @default.
• Q73174775 P2860 Q35617276 @default.
• Q73174775 P2860 Q35833475 @default.
• Q73174775 P2860 Q35834034 @default.
• Q73174775 P2860 Q35976470 @default.
• Q73174775 P2860 Q35979121 @default.
• Q73174775 P2860 Q35982948 @default.
• Q73174775 P2860 Q35984818 @default.
• Q73174775 P2860 Q36233600 @default.
• Q73174775 P2860 Q37782900 @default.
• Q73174775 P2860 Q38481899 @default.
• Q73174775 P2860 Q38482210 @default.
• Q73174775 P2860 Q38486858 @default.
• Q73174775 P2860 Q38487426 @default.
• Q73174775 P2860 Q39402960 @default.
• Q73174775 P2860 Q40133809 @default.

• next